Cloning DNA: From Restriction Digestion to Recombinant DNA Technology

One of the most foundational steps in molecular cloning involves attaching donor DNA (the DNA fragment of interest) to a vector DNA (a carrier molecule). Typically, the donor and the vector DNA are digested using the same restriction enzyme, generating complementary "sticky ends." These sticky ends allow the DNA fragments to naturally anneal when mixed in a test tube, forming recombinant DNA molecules.

For example, Figure 11-5a illustrates a bacterial plasmid containing a single EcoRI restriction site. Digestion with the EcoRI enzyme converts the circular plasmid into a linear molecule with sticky ends. Simultaneously, donor DNA from other sources—such as human genomic DNA—is treated with EcoRI, producing a pool of DNA fragments that possess compatible sticky ends.

When these two DNA populations are mixed under optimal physiological conditions, hybridization occurs. Sticky ends from the plasmid and donor DNA fragments anneal, forming hybrid double helices (Figure 11-5b). Given the diversity of fragments and open plasmids present in the solution, this process generates a wide array of recombinant plasmids, each carrying different donor DNA inserts.

At this point, although the sticky ends are hybridized, the sugar-phosphate backbones are not yet covalently sealed. This critical step is accomplished using DNA ligase, an enzyme that catalyzes the formation of phosphodiester bonds at the junctions (Figure 11-5c). For cDNA cloning, sticky ends may already be present or can be engineered, allowing ligase to efficiently join the DNA fragments to the vector.

Important Considerations:
When aiming to express a cloned gene, such as producing human insulin in bacterial cells, the gene must be inserted adjacent to bacterial regulatory sequences (e.g., promoters and ribosome-binding sites) to enable proper transcription and translation.

---

Amplification Inside Bacterial Cells

Following ligation, the recombinant DNA must be amplified to produce usable quantities. Amplification leverages natural bacterial processes such as transformation, plasmid replication, and cell division. As shown in Figure 11-6, a single recombinant plasmid enters a bacterial cell during transformation. As the cell grows and divides, it replicates its DNA, including the recombinant plasmid.

Each bacterial colony arising from a single transformed cell can harbor billions of copies of the recombinant plasmid, representing an amplified DNA clone. The process relies heavily on the bacterial cell's own DNA replication machinery, which requires an origin of replication—a sequence within the plasmid that ensures its duplication during cell division (refer to Chapter 7 for detailed mechanisms).

---

Choice of Cloning Vectors

Choosing the appropriate vector is essential for successful cloning. Key features of effective cloning vectors include:

• Small size for easy manipulation.

• High replication rate within host cells to ensure amplification.

• Unique restriction sites to allow precise insertion of donor DNA.

• Selectable markers (e.g., antibiotic resistance) to identify successfully transformed cells.

Several classes of cloning vectors are available depending on experimental needs:

---

1. Plasmid Vectors

Plasmids are small, circular DNA molecules capable of autonomous replication. Common plasmids used as vectors often contain antibiotic resistance genes, allowing researchers to easily select transformed cells by growing them on antibiotic-containing media (Figure 11-7).

Furthermore, plasmids usually maintain high copy numbers per cell, making them efficient tools for amplifying cloned DNA. Examples include pUC19, pBR322, and pBluescript plasmids.

---

2. Bacteriophage Vectors

Certain bacteriophages, such as lambda (λ) phage, are employed as cloning vectors, especially when larger DNA fragments need to be cloned. Lambda vectors can accommodate DNA inserts up to about 15 kb.

The λ phage genome is engineered by removing non-essential central regions (using restriction enzymes) and replacing them with donor DNA (Figure 11-8). Recombinant λ particles are then either packaged in vitro or directly transformed into E. coli cells. The appearance of phage plaques on a bacterial lawn indicates successful cloning.

---

3. Vectors for Larger DNA Inserts

When projects demand cloning of very large DNA fragments (e.g., in genomic library construction or genome sequencing), specialized vectors are required:

• Cosmids: Hybrid vectors combining plasmid and phage elements, capable of carrying 35–45 kb inserts. They are introduced into bacteria via phage infection mechanisms but replicate as plasmids once inside the host.

• PACs (P1 Artificial Chromosomes): Derived from the bacteriophage P1 system, PACs can accommodate 80–100 kb inserts.

• BACs (Bacterial Artificial Chromosomes): Originating from the F-plasmid of E. coli, BACs can carry exceptionally large inserts (150–300 kb). BACs were instrumental in large-scale sequencing projects such as the Human Genome Project (Chapter 12).

• YACs (Yeast Artificial Chromosomes): Used for cloning fragments larger than 300 kb. YACs replicate within yeast cells, providing an eukaryotic environment ideal for maintaining enormous DNA inserts.

For the cloning of human insulin, relatively small cDNA fragments (approximately 450 base pairs) were inserted into plasmid vectors, taking advantage of their high efficiency and ease of manipulation.

---

Final Thoughts

Modern recombinant DNA technology relies heavily on the ingenious design and use of vectors. Whether using small plasmids for simple gene cloning or BACs for entire genomic segments, the combination of molecular precision and biological machinery has revolutionized genetics, medicine, and biotechnology.